Pranlukast inhibits NF-κB activation and MUC2 gene expression in cultured human epithelial cells

Pharmacology

Volumn 73, Issue 2, 2005, Pages 89-96

  Ishinaga, Hajime ^a   Takeuchi, Kazuhiko ^a   Kishioka, Chikako ^a   Suzuki, Shinya ^a   Basbaum, Carol ^b   Majima, Yuichi ^a  

^a MIE UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Airway epithelial cells; Lipopolysaccharide; LTD4; Luciferase assay; Nuclear factor B; Phorbol 12 myristate 13 acetate; Pranlukast

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOTRIENE D4; LIPOTEICHOIC ACID; LUCIFERASE; MUCIN 2; MUCIN 5AC; PHORBOL 13 ACETATE 12 MYRISTATE; PRANLUKAST;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

CELL LINE, TUMOR; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE D4; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MUCINS; NF-KAPPA B; RECEPTORS, LEUKOTRIENE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION;

EID: 11444256541     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081294     Document Type: Article

References (35)

1. Dahlen SE, Hedqvist P, Hammarstrom S, Samuelsson B: Leukotrienes are potent constrictors of human bronchi. Nature 1980;288:484-486.
2. Coleman RA, Eglen RM, Jones RL, Narumiya S, Shimizu T, Smith WL, Dahlen SE, Drazen JM, Gardiner PJ, Jackson WT, et al: Prostanoid and leukotriene receptors: A progress report from the IUPHAR working parties on classification and nomenclature. Adv Prostaglandin Thromboxane Leukot Res 1995;23:283-285.
3. Labat C, Ortiz JL, Norel X, Gorenne I, Verley J, Abram TS, Cuthbert NJ, Tudhope SR, Norman P, Gardiner P, et al: A second cysteinyl leukotriene receptor in human lung. J Pharmacol Exp Ther 1992;263:800-805.
4. Piper PJ: Formation and actions of leukotrienes. Physiol Rev 1984;64:744-761.
5. Lewis RA, Austen KF, Soberman RJ: Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990;23:645-655.
6. 1 receptor. Nature 1999;399:789-793.
7. Grossman J, Faiferman I, Dubb JW, Tompson DJ, Busse W, Bronsky E, Montanaro A, Southern L, Tinkelman D: Results of the first US double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist. J Asthma 1997;34:321-328.
8. Uno T, Tanaka H, Nagai H: Cysteinyl leukotrienes do not mediate lipopolysaccharide-induced airway hyperresponsiveness in guinea pigs. Prostaglandins 1996;52:447-461.
9. Ishizaka A, Hasegawa N, Sakamaki F, Tasaka S, Nakamura H, Kishikawa K, Yamada A, Obata T, Sayama K, Urano T, et al: Effects of ONO-1078, peptide leukotriene antagonist, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1994;150:1325-1331.
10. Kawano T, Matsuse H, Kondo Y, Machida I, Saeki S, Tomari S, Mitsuta K, Obase Y, Fukushima C, Shimoda T, Kohno S: Cysteinyl leukotrienes induce nuclear factor kB activation and RANTES production in a murine model of asthma. J Allergy Clin Immunol 2003;112:369-374.
11. Tomari S, Matsuse H, Machida I, Kondo Y, Kawano T, Obase Y, Fukushima C, Shimoda T, Kohno S: Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy 2003;33:795-801.
12. Ichiyama T, Hasegawa S, Umeda M, Terai K, Matsubara T, Furukawa S: Pranlukast inhibits NF-kappa B activation in human monocytes/macrophages and T cells. Clin Exp Allergy 2003;33:802-807.
13. Collart MA, Baeuerle P, Vassalli P: Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four κB-like motifs and constitutive and inducible forms of NF-κB. Mol Cell Biol 1990;10:1498-1506.
14. Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G, et al: Characterization of a functional NF-κB in the human interleukin 1β promoter: Evidence for a positive autoregulatory loop. Mol Cell Biol 1993;13:6231-6240.
15. Kunsh C, Lang RK, Rosen CA, Shannon MF: Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J Immunol 1994;153:153-164.
16. Libermann TA, Baltimore D: Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol Cell Biol 1990;10:2327-2334.
17. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S: Transcription factors NF-IL-6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 1993;90:10193-10197.
18. Li JD, Feng W, Gallup M, Kim JH, Gum J, Kim Y, Basbaum C: Activation of NF-κB via a Src-dependent ras-MARK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci 1998;95:5718-5723.
19. Audie JP, Janin A, Porchet N, Copin MC, Gosselin B, Aubert JP: Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. J Histochem Cytochem 1993;41:1479-1485.
20. 4 and produce eotaxin. J Immunol 2003;170:4290-4295.
21. Karin M, Liu Z, Zandi E: AP-1 function and regulation. Curr Opin Cell Biol 1997;9:240-246.
22. Karin M: The beginning of the end: IκB kinase (IKK) and NF-κB activation. J Biol Chem 1999;274:27339-27342.
23. Adcock IM: Transcription factors as activators of gene transcription: AP-1 and NF-κB. Monaldi Arch Chest Dis 1997;52:178-186.
24. Yang I, Cohn L, Zhang DH, Homer R, Ray A, Ray P: Essential role of NF-κB in the induction of eosinophilia in allergic airway inflammation. J Exp Med 1998;88:1739-1750.
25. Brocks DR, Upward JW, Georgiou P, Stelman G, Doyle E, Allen E, Wyld P, Dennis MJ: The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers. Eur J Clin Pharmacol 1996;51:303-308.
26. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484-496
27. Jaken S: Protein kinase C isozymes and substrates. Curr Opin Cell Biol 1996;8:168-173.
28. Parekh DB, Ziegler W, Parker PJ: Multiple pathways control protein kinase C phosphorylation. EMBO J 2000;19:496-503.
29. Lee HW, Ahn DH, Crawley SC, Li JD, Gum JR Jr, Basbaum CB, Fan NQ, Szymkowski DE, Han SY, Lee BH, Sleisenger MH, Kim YS: Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF-κB. J Biol Chem 2002;277:32624-32631.
30. Savov JD, Gavett SH, Brass DM, Costa DL, Schwartz DA: Neutrophils play a critical role in development of LPS-induced airway disease. Am J Physiol 2002;283:L952-962.
31. Kaisho T, Akira S: Toll-like receptors as advent receptors. Biochim Biophys Acta 2002;1589:1-13.
32. Wang B, Lim DJ, Han J, Kim YS, Basbaum CB, Li JD: Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J Biol Chem 2002 11;277:949-957.
33. Ueda T, Takeno S, Furukido K, Hirakawa K, Yajin K: Leukotriene receptor antagonist pranlukast suppresses eosinophil infiltration and cytokine production in human nasal mucosa of perennial allergic rhinitis. Ann Otol Rhinol Laryngol 2003;112:955-961.
34. Tohda Y, Nakahara H, Kubo H, Haraguchi R, Fukuoka M, Nakajima S: Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma. Clin Exp Allergy 1999;29:1532-1536.
35. Tamaoki J, Kondo M, Sakai N, Nakata J, Takemura H, Nagai A, Takizawa T, Konno K: Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group. Am J Respir Crit Care Med 1997;155:1235-1240.